Pidolic acid

DB03088ApprovedInvestigationalSmall molecule

Pidolic acid is a naturally occurring but little-studied amino acid derivative that can be formed enzymatically or non-enzymatically and participates as a biological intermediate with unique pharmacodynamics in various chemical... Elevations of the acid in blood levels may be associated with problems of glutamine or glutathione metabolism.

Chemical structure of Pidolic acid
Mechanism
Curator reviewed · 11 references
Primary indication
There is currently no clinically approved and/or marketed medicine that relies upon pidolic acid as an active ingredient for any formal therapeutic indication.Curator reviewed · 2 structured indications
Formula / weight
C5H7NO3 · 129.114 g/mol (avg)
First approval
Canada, 1980
Also known as
Glutimic acid · pyroglutamate · Pyroglutamic acid

Resolves to

Clinical / RWD
Structure
InChIKeyODHCTXKNWHHXJC-VKHMYHEASA-NSMILESOC(=O)[C@@H]1CCC(=O)N1

What you can answer from here — as of September 23, 2026

14Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
12Marketed productsAcross 3 countries and 6 labellers
Sign in
1ATC codeIncluding every combination product, plus 10 drug categories
Sign in
19+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Pidolic acid, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account